Viorel Manole
Family Medicine · Church Hill, TNNPI 1639172711
Payments from drug & device makers
Across 117 payments — averaging $15.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$438
- GSK$293
- AstraZeneca$207
- Novo Nordisk$159
- Novartis$103
- Amgen$76
- plus $569 from 16 others
What the payments were for
- Speaking & faculty fees$452%
- Food & beverage$1,80098%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 34 | $438 |
| GSK | 21 | $293 |
| AstraZeneca | 8 | $207 |
| Novo Nordisk | 11 | $159 |
| Novartis | 5 | $103 |
| Amgen | 6 | $76 |
| Astellas Pharma US Inc | 4 | $74 |
| Pfizer | 3 | $69 |
| Sanofi-aventis U.S. LLC | 3 | $53 |
| Boehringer Ingelheim | 3 | $49 |
| Bayer | 3 | $46 |
| Dexcom, Inc. | 2 | $42 |
| Amarin Pharma, Inc. | 2 | $38 |
| Alkermes, Inc. | 1 | $29 |
| E.r. Squibb & Sons, L.L.C. | 2 | $28 |
| Eisai Inc. | 2 | $26 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 2 | $25 |
| Sumitomo Pharma America, Inc. | 1 | $21 |
| Esperion Therapeutics, Inc. | 1 | $20 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $18 |
| Lundbeck LLC | 1 | $16 |
| Xeris Pharmaceuticals, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FARXIGA$114
How this compares
$1,845 in reported general payments places this provider in the 65th percentile of 2,087 family medicine providers in Tennessee.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 25 | $29,125 |
| OzempicSemaglutide | 19 | $19,395 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 17 | $13,387 |
| JanuviaSitagliptin Phosphate | 13 | $10,055 |
| FarxigaDapagliflozin Propanediol | 11 | $9,137 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 24 | $2,453 |
| Atorvastatin Calcium | 124 | $2,274 |
| Pantoprazole Sodium | 88 | $1,242 |
| Omeprazole | 64 | $1,082 |
| Pravastatin Sodium | 46 | $833 |
| Rosuvastatin Calcium | 43 | $778 |
| Levothyroxine Sodium | 126 | $758 |
| Losartan Potassium | 55 | $733 |
| Lisinopril | 110 | $730 |
| Ezetimibe | 17 | $723 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $69 | $29,12525 claims |
| Novo NordiskOzempic | $159 | $19,39519 claims |
| GSKTrelegy Ellipta | $293 | $13,38717 claims |
| AstraZenecaFarxiga | $207 | $9,13711 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 2,087 family medicine providers in Tennessee.
Other family medicine in Church Hill
- Rickey ManningKnoxville$8.1M
- Kymberly MoyerGallatin$5.9M
- Natasha BallardChattanooga$5.7M
- Hina BudhwaniNashville$4.7M
- Paul WakefieldKnoxville$4.3M
- Emily HubbsKingsport$2.8M
- Jerry PunchKnoxville$2.1M
- Bridgette FraneyNashville$2M
- Andrew BrockmyreBristol$1.8M
- Marcus LeeTullahoma$1.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.